Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Theravance Biopharma, Inc. - Ordinary Shares (NQ:TBPH)

13.68 -0.28 (-2.01%)

Streaming Delayed Price Updated: 3:54 PM EST, Mar 4, 2026 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	1,166,065
Open	13.37
Bid (Size)	13.68 (500)
Ask (Size)	13.70 (300)
Prev. Close	13.96
Today's Range	13.25 - 14.10
52wk Range	7.900 - 21.03
Shares Outstanding	49,471,000
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

What's going on in today's session ↗

March 03, 2026

Via Chartmill

These stocks are moving in today's session ↗

March 03, 2026

Via Chartmill

Performance

YTD	-24.6%	-24.6%
1 Month	-31.0%	-31.0%
3 Month	-25.8%	-25.8%
6 Month	-1.2%	-1.2%
1 Year	+49.5%	+49.5%

More News

TBPH Stock Slumps 30%, Falls Below 200-DMA For First Time In Over 9 Months As Phase 3 Study Misses Primary Endpoint ↗

March 03, 2026

Via Stocktwits

Which stocks are gapping on Tuesday? ↗

March 03, 2026

Via Chartmill

Theravance Biopharma Inc (NASDAQ:TBPH) Shows Strong Technical and Fundamental Momentum ↗

February 11, 2026

Via Chartmill

Surgery Partners Stock Down 39% as One Fund Slashes Stake by $19 Million ↗

February 23, 2026

Via The Motley Fool

Alkami Stock Down 50%, But This New $49 Million Stake Signals Conviction in a Turnaround ↗

February 23, 2026

Via The Motley Fool

Integer Holdings Lands New $99 Million Stake Even With Stock Down Over 30% This Past Year ↗

February 23, 2026

Via The Motley Fool

Fund Builds $40 Million SPS Commerce Stake as Shares Sink 60% Despite 100 Straight Growth Quarters ↗

February 23, 2026

Via The Motley Fool

Vistance Networks Stock Up 250%. Here's Why a $40 Million Position Signals a Post-Divestiture Bet ↗

February 22, 2026

Via The Motley Fool

Array Stock Down 25%, But This $17.3 Million Buy Signals Confidence Amid Big Revenue Growth ↗

February 22, 2026

Via The Motley Fool

Enviri Stock Up 120% as $43 Million Buy Makes It a Top Holding in This Portfolio ↗

February 22, 2026

Via The Motley Fool

Integer Stock Down 38%, but One Fund Just Bet $40 Million on a Turnaround ↗

February 22, 2026

Via The Motley Fool

Irenic Dumps Most Papa John's Shares ↗

February 22, 2026

Via The Motley Fool

Stay updated with the stocks that are on the move in today's pre-market session. ↗

January 26, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Friday. ↗

January 23, 2026

Via Chartmill

These stocks that are showing activity before the opening bell on Tuesday. ↗

January 13, 2026

Via Chartmill

Millrose Properties Stock Has Surged 48% Since February Debut — So Why Did One Investor Sell a $23 Million Stake? ↗

December 07, 2025

Via The Motley Fool

Why One Investor Bought $67.5 Million in Array Digital Infrastructure Stock ↗

December 07, 2025

Via The Motley Fool

Why One Value Fund Has a $101 Million Bet on Indivior Stock Amid a 212% Surge ↗

December 07, 2025

Via The Motley Fool

Why One Value Fund Just Bought $30 Million of a Diagnostics Stock Down 90% From Pandemic-Era Highs ↗

December 07, 2025

Via The Motley Fool

Top movers analysis one hour before the close of the markets on 2025-11-11: top gainers and losers in today's session. ↗

November 11, 2025

Via Chartmill

Here's Why Shares in Theravance Biopharma Exploded Today ↗

November 11, 2025

Via The Motley Fool

12 Health Care Stocks Moving In Tuesday's Intraday Session ↗

November 11, 2025

Via Benzinga

Theravance Biopharma Inc (NASDAQ:TBPH) Reports Q3 2025 Earnings Beat Amid Muted Market Reaction ↗

November 10, 2025

Via Chartmill

Frequently Asked Questions

Is Theravance Biopharma, Inc. - Ordinary Shares publicly traded?

Yes, Theravance Biopharma, Inc. - Ordinary Shares is publicly traded.

What exchange does Theravance Biopharma, Inc. - Ordinary Shares trade on?

Theravance Biopharma, Inc. - Ordinary Shares trades on the Nasdaq Stock Market

What is the ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares?

The ticker symbol for Theravance Biopharma, Inc. - Ordinary Shares is TBPH on the Nasdaq Stock Market

What is the current price of Theravance Biopharma, Inc. - Ordinary Shares?

The current price of Theravance Biopharma, Inc. - Ordinary Shares is 13.68

When was Theravance Biopharma, Inc. - Ordinary Shares last traded?

The last trade of Theravance Biopharma, Inc. - Ordinary Shares was at 03/04/26 03:54 PM ET

What is the market capitalization of Theravance Biopharma, Inc. - Ordinary Shares?

The market capitalization of Theravance Biopharma, Inc. - Ordinary Shares is 676.76M

How many shares of Theravance Biopharma, Inc. - Ordinary Shares are outstanding?

Theravance Biopharma, Inc. - Ordinary Shares has 677M shares outstanding.

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.